Rectal gel application of Withania somnifera root extract expounds anti-inflammatory and muco-restorative activity in TNBS-induced Inflammatory Bowel Disease

BMC Complementary and Alternative Medicine

Volumn 11, Issue , 2011, Pages

  Pawar, Pankaj ^a,b   Gilda, Suhit ^a   Sharma, Siddhesh ^a   Jagtap, Suresh ^a,b   Paradkar, Anant ^a   Mahadik, Kakasaheb ^a   Ranjekar, Prabhakar ^a,b   Harsulkar, Abhay ^a,b  

^a BHARATI VIDYAPEETH DEEMED UNIVERSITY   (India)

^b Bharati Vidyapeeth Deemed University   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID; CURCUMIN; FERRIC ION; HYDROGEN PEROXIDE; MALONALDEHYDE; MESALAZINE; NITRIC OXIDE; TRINITROBENZENESULFONIC ACID; WITHANIA SOMNIFERA EXTRACT; ANTIINFLAMMATORY AGENT; NITROUS OXIDE; PLANT EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; AQUEOUS SOLUTION; ARTICLE; COLITIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; EDEMA; ENTERITIS; FEMALE; GEL; HISTOPATHOLOGY; INTESTINE MUCOSA; INTESTINE NECROSIS; LIPID PEROXIDATION; MALE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PLANT ROOT; RAT; WITHANIA SOMNIFERA; ANIMAL; DRUG EFFECT; METABOLISM; PATHOLOGY; PHYTOTHERAPY; REFERENCE VALUE; WISTAR RAT; WITHANIA;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; FEMALE; GELS; HYDROGEN PEROXIDE; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; LIPID PEROXIDATION; MALE; NITROUS OXIDE; PHYTOTHERAPY; PLANT EXTRACTS; PLANT ROOTS; RATS; RATS, WISTAR; REFERENCE VALUES; TRINITROBENZENESULFONIC ACID; WITHANIA;

EID: 79955156590     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-11-34     Document Type: Article

References (44)

1. Bhattacharya A, Ghosal S, Bhattacharya SK. Anti-oxidant effect of Withania somnifera glycowithanolides in chronic footshock stress-induced perturbations of oxidative free radical scavenging enzymes and lipid peroxidation in rat frontal cortex and striatum. J Ethnopharmacol 2001, 74:1-6. 10.1016/S0378-8741(00)00309-3, 11137343.
2. Tripathy AK, Shukla YN, Kumar S. W. somnifera [Withania somnifera] Dunal [Solanaceae]: A status report. J Med Arom Plant Sci 1996, 18:46-62.
3. Jayaprakasam B, Nair MG. Cyclooxygenase-2 inhibitory withanolides from leaves of Withania somnifera. Tetrahedron 2003, 59:841-849.
4. Jayaprakasam B, Strasburg GA, Nair MG. Potent lipid peroxidation inhibitors from Withania somnifera fruits. Tetrahedron 2004, 60:3109-3121.
5. Al-Hindwani MK, Al-Khafaji SH, Abdul-Nabi MH. Anti-granuloma activity of Iraqi Withania somnifera. J Ethnopharmacol 1992, 37:113-116. 10.1016/0378-8741(92)90069-4, 1434685.
6. Devi PU. Withania somnifera Dunal [W. somnifera]: Potential plant source of a promising drug for cancer chemotherapy and radiosensitization. Ind J Expt Biol 1996, 34:927-932.
7. Russo A, Izzo AA, Cardile V, Borrelli F, Vanella A. Indian medicinal plants as antiradicals and DNA cleavage protectors. Phytomed 2001, 8:125-132.
8. Rasool M, Marylatha L, Varalakshmi P. Effect of Withania somnifera on lysosomal acid hydrolases in adjuvant-induced arthritis in rats. Pharma Pharmacol Comm 2000, 6:187-190.
9. Rasool M, Varalakshmi P. Immunomodulatory role of Withania somnifera root powder on experimentally induced inflammation: An in vivo and in vitro study. Vascular Pharmacol 2006, 44:406-410.
10. Luvone T, Esposito G, Capasso F, Izzo A. Induction of nitric oxide synthase expression by Withania somnifera in macrophages. Life Sci 2003, 72:1617-1625. 10.1016/S0024-3205(02)02472-4, 12551750.
11. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterol 1998, 115:183-205.
12. Jagtap AG, Shirke SS, Phadke AS. Effect of polyherbal formulation on experimental models of inflammatory bowel diseases. J Ethnopharmacol 2004, 90:195-204. 10.1016/j.jep.2003.09.042, 15013181.
13. Gurudu S, Fiocchi C, Katz JA. Inflammatory bowel disease. Best Pract Res Clin Gastroenterol 2002, 16:77-90. 10.1053/bega.2001.0267, 11977930.
14. Rezaie A, Parker RD, Abdollahi M. Oxidative stress and pathogenesis of inflammatory bowel disease: an epiphenomenon or the cause?. Dig Dis Sci 2007, 52:2015-2021. 10.1007/s10620-006-9622-2, 17404859.
15. Pavlick KP, Laroux FS, Fuseler J, Wolf RE, Gray L, Hoffman J, Grisham MB. Role of reactive metabolites of oxygen and nitrogen in inflammatory bowel disease. Free Rad Biol Med 2002, 33:311-322.
16. Harputluoglu M, Demirel U, Yucel N, Karadag N, Temel I, Firat N, Ara C, Aladaǧ M, Karincaoǧlu M, Hilmioǧlu F. The effect of Gingko biloba extract on acetic acid on acetic acid induced colitis in rats. Turk J Gastroenterol 2006, 17:177-182.
17. Miles AM, Grisham MB. Antioxidant properties of amino-salicylates. Methods Enzymol 1994, 234:555-572.
18. Rahimi R, Mozaffari S, Abdollahi M. On the use of herbal medicines in management of inflammatory bowel diseases: a systematic review of animal and human studies. Dig Dis Sci 2009, 54:471-480. 10.1007/s10620-008-0368-x, 18618255.
19. Sugimoto K, Hanai H, Tozawa K, Aoshi T, Uchijima M, Nagata T, Koide Y. Curcumin prevents and ameliorates trinitrobenzenersulfonic acid-induced colitis in mice. Gastroenterol 2002, 123:1912-1922.
20. Ukil A, Maity S, Karmarkar S, Datta N, Vedasiromoni JR, Das PK. Curcumin, the major component of food flavour turmeric, reduces mucosal injury in trinitrobenzene sulphonic acid-induced colitis. Br J Pharmacol 2003, 139:209-218. 10.1038/sj.bjp.0705241, 1573841, 12770926.
21. Salh B, Assi K, Templeman V, Parhar K, Owen D, Gomez-Munoz A, Jacobson K. Curcumin attenuates DNB-induced murine colitis. Am J Physiol Gastrointest Liver Physiol 2003, 285:235-243.
22. Jian YT, Mai GF, Wang JD, Zhang YL, Luo RC, Fang YX. Preventive and therapeutic effects of NF-kappa B inhibitor curcumin in rats colitis induced by trinitrobenzene sulfonic acid. World J Gastroenterol 2005, 1:1747-1752.
23. Shastry MK, Yadava RK, Singh RH. Effect of vasti therapy in the management of irritable bowel syndrome (Pakwasayagata vata Vyadhi). J Res Ayurveda Siddha 1996, 17:16-19.
24. Wade J, Van R. Quantitation of malonaldehyde [MDA] in plasma, by ion-pairing reverse phase high performance liquid chromatography. Biochem Med 1985, 33:291-296. 10.1016/0006-2944(85)90003-1, 4015630.
25. Sreejayan N, Rao MNA. Nitric oxide scavenging by curcuminoids. J Pharm Pharmacol 1997, 49:105-107.
26. Ruch RJ, Cheng SJ, Klaunig JE. Prevention of Cytotoxicity and inhibition of intracellular communication by antioxidant catechins isolated from Chinese green tea. Carcinogenesis 1989, 10:1003-1008. 10.1093/carcin/10.6.1003, 2470525.
27. Mau EL. Antioxidant properties of several medicinal mushrooms. J Agri Food Chem 2002, 50:6072-6077.
28. Elson CO, Sartor RB, Tennyson GS, Riddell RH. Experimental models of inflammatory bowel disease. Gastroenterol 1995, 109:1344-1367.
29. Wallace JL, Kinnan CM. An orally active inhibitor of leukotriene synthesis accelerates healing in a rat model of colitis. Am J Physiol 1990, 258:527-534.
30. Elson CO, Beagley KW, Sharmanov AT, Fujihashi K, Kiyono H, Tennyson GS, Cong Y, Black CA, Ridwan BW, McGhee JR. Hapten-induced model of murine inflammatory bowel disease: mucosal immune responses and protection by tolerance. J Immunol 1996, 157:2174-2185.
31. Neurath M, Fuss I, Kelshall B, Stuber E, Strober W. Antibodies to interleukin 12 abrogate established experimental colitis in mice. J Expt Med 1995, 182:1281-1290.
32. Ilan Y, Weksler-Zangen S, Ben-Horin S, Diment J, Sauter B, Rahbani E, Engelhardt D, Chowdhury NR, Chowdhury JR, Goldin E. Treatment of experimental colitis by oral tolerance induction: A central role for suppressor lymphocytes. Am J Gastroenterol 2000, 95:966-973. 10.1111/j.1572-0241.2000.01935.x, 10763946.
33. Devise MG, Hagen PO. Systemic inflammatory response syndrome. Br J Surg 1997, 84:920-935. 10.1002/bjs.1800840707, 9240130.
34. Siebenlist U, Franzoso G, Brown K. Regulation and function of NF-kappa B. Annual Rev Cell Biol 1994, 10:405-455.
35. Schreck R, Albermann K, Baeuerle PA. Nuclear factor kappa B: an oxidative stress-responsive transcription factor of eukaryotic cells [a review]. Free Radic Res Commun 1992, 17:221-237. 10.3109/10715769209079515, 1473734.
36. Halliwell B. Free radicals, anti-oxidants and human diseases: curiosity, cause or consequence. Lancet 1994, 344:721-724. 10.1016/S0140-6736(94)92211-X, 7915779.
37. Jahanshahi G, Motavasel V, Rezaie A, Hashtroudi AA, Daryani NE, Abdollahi M. Alterations in antioxidant power and levels of epidermal growth factor and nitric oxide in saliva of patients with inflammatory bowel diseases. Dig Dis Sci 2004, 49:1752-1757. 10.1007/s10620-004-9564-5, 15628697.
38. Keshavarzian A, Sedghi S, Kanofsky J, List T, Robinson C, Ibrahim C, Winship D. Excessive production of reactive oxygen metabolites by inflammed colon: Analysis by chemi-luminescence probe. Gastroenterol 1992, 103:177-185.
39. Simmonds NJ, Allen RE, Stevens TR, van Someren RN, Blake DR, Rampton DS. Chemiluminescence assay of mucosal reactive oxygen metabolites in inflammatory bowel disease. Gastroenterol 1992, 103:186-196.
40. Grisham MB, Volkmer C, Tso P, Yamada T. Metabolism of trinitrobenzene sulfonic acid by the rat colon produces reactive oxygen species. Gastroenterol 1991, 101:540-547.
41. Bhatnagar M, Sisodia SS, Bhatnagar R. Anti-ulcer and antioxidant activity of Asparagus racemosa WILD and Withania somnifera DUNAL in rats. Ann N Y Acad Sci 2005, 105:261-278.
42. Mishra LC, Singh BB, Dagenais S. Scientific basis for the therapeutic use of Withania somnifera [Ashwagandha]: A review. Alternative Med Rev 2000, 5:334-346.
43. Amini-Shirazi N, Hoseini A, Ranjbar A, Mohammadirad A, Khoshakhlagh P, Yasa N, Abdollahi M. Inhibition of tumor necrosis factor and nitrosative/oxidative stresses by Ziziphora clinopoides (Kahlioti); a molecular mechanism of protection against dextran sodium sulfate-induced colitis in mice. Toxicol Mech Methods 2009, 19:183-189. 10.1080/15376510701533996, 19778264.
44. Abdolghaffari AH, Baghaei A, Moayer F, Esmaily H, Baeeri M, Monsef-Esfahani HR, Hajiaghaee R, Abdollahi M. On the benefit of Teucrium in murine colitis through improvement of toxic inflammatory mediators. Hum Exp Toxicol 2010, 29:287-295. 10.1177/0960327110361754, 20144954.